An implantable cardiac monitor is a small monitoring device, which is used to record the electrical activity of the heart. The device is embedded under the skin of the patient’s chest from where the heart’s electrical activity is recorded. The device can be activated either by adjusting the heart rate according to the range set by the physician or can be externally triggered with the push of a button. These recordings are used by the physicians to analyze and identify an abnormal heart rhythm. The device is used to monitor patients who are at risk for myocardial infraction and atrial fibrillation. The global implantable cardiac monitors market was valued at $410.4 million in 2016, and is expected to reach at $678.3 million by 2023, registering a CAGR of 7.4% from 2017 to 2023. Research Beam Model: Research Beam Product ID: 2778359 5370 USD New
Implantable Cardiac Monitors Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User (Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Implantable Cardiac Monitors Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User (Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : December  2017
  • Pages : 207
 
 

An implantable cardiac monitor is a small monitoring device, which is used to record the electrical activity of the heart. The device is embedded under the skin of the patient’s chest from where the heart’s electrical activity is recorded. The device can be activated either by adjusting the heart rate according to the range set by the physician or can be externally triggered with the push of a button. These recordings are used by the physicians to analyze and identify an abnormal heart rhythm. The device is used to monitor patients who are at risk for myocardial infraction and atrial fibrillation. The global implantable cardiac monitors market was valued at $410.4 million in 2016, and is expected to reach at $678.3 million by 2023, registering a CAGR of 7.4% from 2017 to 2023.

A major factor that drives implantable cardiac monitors market is their longevity. In addition, the implantable nature does not require any admission to the hospital, and the patient can be monitored while performing the daily activities. Moreover, rise in incidence of patients suffering from atrial fibrillation, increase in prevalence of myocardial infraction, and unhealthy lifestyle are some other factors that boost the market growth. However, availability of alternative mode of treatment and inflated cost of device hamper the market growth. Conversely, increase in awareness among patients these devices and treatment options for management of cardiac disorders provide lucrative market growth opportunities.

The global implantable cardiac monitors market is segmented based on indication, end user, and region. On the basis of indication, the market is divided into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls. By end user, it is classified into hospitals, cardiac centers & clinics and ambulatory surgical centers (ASCs).

Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to increase in development of sophisticated cardiac devices and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, due to the improvements in healthcare facilities, increase in disposable income, and improvement in economic conditions.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global implantable cardiac monitors market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry, which helps understand the type of products and technologies used globally is included.
  • Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Indication

  • Cardiac Arrhythmias
  • Atrial Fibrillation
  • Epilepsy & Unexplained Falls

By End User

  • Hospitals
  • Cardiac Centers & Clinics
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Malaysia
    • New Zealand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Egypt
    • Rest of LAMEA

KEY PLAYERS PROFILED

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Edwards Lifescience Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • Phoenix Heart Center

The other players in the value chain include (profiles not included in the report)

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Jarvik Heart, Inc.
  • ReliantHeart Inc.
  • Schiller AG
  • Astellas Pharma, Inc.
  • Sigma-Aldrich Corporation
  • Agilent Technologies, Inc.
  • Basilea Pharmaceutical Ltd.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017*
3.2.2.2. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.2.3. Top Winning Strategies, By Company, 2014-2017*

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Extended durability of implantable cardiac monitors
3.5.1.2. Less hospital stay and fewer hospital readmission
3.5.1.3. Rise in incidence of atrial fibrillation, myocardial infraction, and arrhythmias

3.5.2. Restraints

3.5.2.1. Availability of alternative mode of treatment
3.5.2.2. High cost of implantable cardiac monitors

3.5.3. Opportunity

3.5.3.1. Increase in awareness about devices and treatment options for cardiac disorders

CHAPTER 4 IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CARDIAC ARRHYTHMIAS

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast by region
4.2.1. Market size and forecast by country

4.3. ATRIAL FIBRILLATION

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country

4.4. EPILEPSY & UNEXPLAINED FALLS

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country

CHAPTER 5 IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country

5.3. CARDIAC CENTERS & CLINICS

5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country

CHAPTER 6 IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by country
6.2.3. North America market size and forecast, by indication
6.2.4. North America market size and forecast, by end user

6.2.4.1. U.S., market size and forecast by Indication
6.2.4.2. U.S., market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by indication
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by indication
6.2.4.6. Mexico market size and forecast, by end user

6.3. EUROPE

6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by country
6.3.3. Europe market size and forecast, by indication
6.3.4. Europe market size and forecast, by end user

6.3.4.1. Germany market size and forecast, by indication
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by indication
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by indication
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by indication
6.3.4.8. Italy market size and forecast, by end user
6.3.4.9. Spain market size and forecast, by indication
6.3.4.10. Spain market size and forecast, by end user
6.3.4.11. Switzerland market size and forecast, by indication
6.3.4.12. Switzerland market size and forecast, by end user
6.3.4.13. Rest of Europe market size and forecast, by indication
6.3.4.14. Rest of Europe market size and forecast, by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.3. Asia-Pacific market size and forecast, by indication
6.4.4. Asia-Pacific market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by indication
6.4.4.2. Japan market size and forecast, by end user
6.4.4.3. China market size and forecast, by indication
6.4.4.4. China market size and forecast, by end user
6.4.4.5. Australia market size and forecast, by indication
6.4.4.6. Australia market size and forecast, by end user
6.4.4.7. India market size and forecast, by indication
6.4.4.8. India market size and forecast, by end user
6.4.4.9. Malaysia market size and forecast, by indication
6.4.4.10. Malaysia market size and forecast, by end user
6.4.4.11. New Zealand market size and forecast, by indication
6.4.4.12. New Zealand market size and forecast, by end user
6.4.4.13. Rest of Asia-Pacific market size and forecast, by indication
6.4.4.14. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.3. LAMEA market size and forecast, by indication
6.5.4. LAMEA market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by indication
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. South Africa market size and forecast, by indication
6.5.4.4. South Africa market size and forecast, by end user
6.5.4.5. Egypt market size and forecast, by indication
6.5.4.6. Egypt market size and forecast, by end user
6.5.4.7. Rest of LAMEA market size and forecast, by indication
6.5.4.8. Rest of LAMEA market size and forecast, by end user

CHAPTER 7 COMPANY PROFILE

7.1. ABBOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments

7.2. BIOTRONIK SE & CO. KG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Key strategic moves and developments

7.3. BOSTON SCIENTIFIC CORPORATION

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance

7.4. EDWARDS LIFE SCIENCE CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance

7.5. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance

7.6. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance

7.7. LIVANOVA PLC (SORIN)

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance

7.8. MEDTRONIC PLC

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments

7.9. NIHON KOHDEN CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance

7.10. PHOENIX HEART PLLC

7.10.1. Company overview
7.10.2. Operating business segments

LIST OF TABLES

TABLE 1. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 2. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC ARRHYTHMIAS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. IMPLANTABLE CARDIAC MONITOR MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2016-2023 ($MILLION)
TABLE 4. IMPLANTABLE CARDIAC MONITOR MARKET FOR EPILEPSY & UNEXPLAINED FALLS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 6. IMPLANTABLE CARDIAC MONITOR MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC CENTERS & CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. IMPLANTABLE CARDIAC MONITOR MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2016-2023 ($MILLION)
TABLE 9. IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 12. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 13. U.S. IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 14. U.S. IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 15. CANADA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 16. CANADA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 17. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 18. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 21. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 22. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 23. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 25. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 26. UK IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 27. UK IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 28. ITALY IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 29. ITALY IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 31. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 32. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 33. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 34. REST OF EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 35. REST OF EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 39. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 40. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. CHINA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 42. CHINA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 43. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 44. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. INDIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 46. INDIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 47. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 48. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 49. NEW ZEALAND IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 50. NEW ZEALAND IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 54. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 55. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 56. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 57. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 58. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 59. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 60. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 61. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 62. REST OF LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 63. REST OF LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 64. ABBOTT: COMPANY SNAPSHOT
TABLE 65. ABBOTT: OPERATING SEGMENTS
TABLE 66. BIOTRONIK: COMPANY SNAPSHOT
TABLE 67. BIOTRONIK: OPERATING SEGMENTS
TABLE 68. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 69. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 70. EDWARD LIFESCIENCE: COMPANY SNAPSHOT
TABLE 71. EDWARD LIFESCIENCE: OPERATING SEGMENTS
TABLE 72. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 73. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 74. PHILIPS: COMPANY SNAPSHOT
TABLE 75. PHILIPS: OPERATING SEGMENTS
TABLE 76. LIVANOVA: COMPANY SNAPSHOT
TABLE 77. LIVANOVA: OPERATING SEGMENTS
TABLE 78. MEDTRONIC: COMPANY SNAPSHOT
TABLE 79. MEDTRONIC: OPERATING SEGMENTS
TABLE 80. NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 81. NIHON KOHDEN: PRODUCT CATEGORIES
TABLE 82. PHOENIX HEART, PLLC:COMPANY SNAPSHOT
TABLE 83. PHOENIX HEART, PLLC: PRODUCT CATEGORIES

LIST OF FIGURES

FIGURE 1. TOTAL NUMBER OF IMPLANTABLE CARDIAC MONITOR PROCEDURES PERFORMED FROM 2016 TO 2023
FIGURE 2. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, 2016-2023
FIGURE 3. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION, 2016-2023
FIGURE 4. SEGMENTATION OF GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, 2016-2023
FIGURE 5. TOP INVESTMENT POCKETS
FIGURE 6. MODERATE BARGAINING POWER OF BUYERS
FIGURE 7. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 8. HIGH THREAT OF NEW ENTRANTS
FIGURE 9. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS: IMPLANTABLE CARDIAC MONITOR MARKET, 2016
FIGURE 12. KEY DEVELOPMENTS FOR IMPLANTABLE CARDIAC MONITORS BY MEDTRONIC PLC
FIGURE 13. RESTRAINTS AND DRIVERS: GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET
FIGURE 14. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET: BY INDICATION
FIGURE 15. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC ARRHYTHMIAS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 16. IMPLANTABLE CARDIAC MONITOR MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 17. IMPLANTABLE CARDIAC MONITOR MARKET FOR EPILEPSY & UNEXPLAINED FALLS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 18. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER
FIGURE 19. IMPLANTABLE CARDIAC MONITOR MARKET FOR HOSPITALS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 20. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC CENTERS & CLINICS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 21. IMPLANTABLE CARDIAC MONITOR MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 22. IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION
FIGURE 23. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 24. ABBOTT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 25. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 26. BOSTON SCIENTIFIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 27. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 28. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 29. EDWARD LIFESCIENCE: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. EDWARD LIFESCIENCE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 31. EDWARD LIFESCIENCE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 32. GE HEALTHCARE: REVENUE, 2014-2016 ($MILLION)
FIGURE 33. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. PHILIPS: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 37. LIVANOVA: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. LIVANOVA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. LIVANOVA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 40. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 41. MEDTRONIC: REVENUE BY SEGMENT, 2017 (%)
FIGURE 42. MEDTRONIC: REVENUE BY GEOGRAPHY, 2017 (%)
FIGURE 43. NIHON KOHDEN: NET SALES, 2015-2017 ($MILLION)
FIGURE 44. NIHON KOHDEN: REVENUE BY PRODUCT, 2017 (%)
FIGURE 45. NIHON KOHDEN: REVENUE BY GEOGRAPHY, 2017 (%)